Form 4 Tracker
PRECISION BIOSCIENCES INC
DTIL

22 insider filings · Latest: Jun 3, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Feb 18, 2026Feb 19 9:31 PMMichael AmorosoDirector, President and CEO
Sale
20,559$3.84$78.9K243,392(D)

View →

Feb 18, 2026Feb 19 9:31 PMJohn Alexander KellyChief Financial Officer
Sale
8,149$3.84$31.3K125,883(D)

View →

Feb 18, 2026Feb 19 9:30 PMDario ScimecaGeneral Counsel and Secretary
Sale
4,925$3.84$18.9K56,457(D)

View →

Feb 18, 2026Feb 19 9:30 PMJefferson J. SmithChief Research Officer
Sale
4,925$3.84$18.9K121,926(D)

View →

Feb 18, 2026Feb 18 10:05 PMSMITH J. JEFFERSON
Proposed Sale
4,925$3.84$18.9K

View →

Feb 18, 2026Feb 18 9:31 PMScimeca Dario
Proposed Sale
4,925$3.84$18.9K

View →

Feb 18, 2026Feb 18 9:30 PMAmoroso Michael
Proposed Sale
20,559$3.84$79.0K

View →

Feb 18, 2026Feb 18 9:19 PMKelly John Alexander
Proposed Sale
8,149$3.84$31.3K

View →

Jan 22, 2026Jan 22 11:49 PMMichael AmorosoDirector, President and CEO
Sale
34,799$4.17$145.1K196,154(D)

View →

Jan 21, 2026Jan 22 11:48 PMDario ScimecaGeneral Counsel and Secretary
Sale
8,854$4.03$35.7K44,715(D)

View →

Jan 21, 2026Jan 22 11:48 PMJohn Alexander KellyChief Financial Officer
Sale
15,213$4.03$61.3K106,448(D)

View →

Jan 21, 2026Jan 22 11:48 PMJefferson J. SmithChief Research Officer
Sale
10,200$4.03$41.1K110,184(D)

View →

Jan 22, 2026Jan 22 8:19 PMAmoroso Michael
Proposed Sale
34,799$4.17$145.2K

View →

Jan 21, 2026Jan 21 9:19 PMScimeca Dario
Proposed Sale
8,854$4.03$35.7K

View →

Jan 21, 2026Jan 21 9:14 PMSMITH J. JEFFERSON
Proposed Sale
10,200$4.03$41.1K

View →

Jan 21, 2026Jan 21 9:07 PMKelly John Alexander
Proposed Sale
15,213$4.03$61.3K

View →

Nov 3, 2025Nov 3 8:16 PMKelly John Alexander
Proposed Sale
1,303$6.49$8.5K

View →

Nov 3, 2025Nov 3 8:15 PMAmoroso Michael
Proposed Sale
3,409$6.49$22.1K

View →

Nov 3, 2025Nov 3 8:07 PMScimeca Dario
Proposed Sale
665$6.49$4.3K

View →

Jul 3, 2025Jul 3 7:25 PMKelly John Alexander
Proposed Sale
14,827$4.26$63.2K

View →

Page 1 of 2

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jan 20, 2026Jan 22 11:48 PMJohn Alexander KellyChief Financial Officer
Option Exercise
44,36326,575(D)

View →

Jan 20, 2026Jan 22 11:48 PMJefferson J. SmithChief Research Officer
Option Exercise
29,16616,219(D)

View →

← Previous

Page 2 of 2